Does Exsanguination Enhance Skin Microcirculation in Remote Ischemic Conditioning Using a Tourniquet? A Randomized Controlled Trial on 50 Healthy Subjects

使用止血带进行远程缺血预适应时,放血是否能增强皮肤微循环?一项针对50名健康受试者的随机对照试验

阅读:1

Abstract

BACKGROUND: Remote Ischemic Conditioning (RIC) improves cutaneous microcirculation in free flap surgery. As no universal RIC protocol exists, refinements have mainly focused on cycle duration and number. We aimed to assess whether ischemic stimulus intensity, using a tourniquet with additional exsanguination, affects cutaneous microcirculation. METHODS: In this randomized controlled trial, 50 healthy volunteers were randomized into two groups (25 each). Both underwent an RIC protocol of three cycles of 10-minute ischemia followed by 10-minute reperfusion. In the control group (Tourniquet, T), ischemia was induced with a surgical tourniquet inflated to 250 mm Hg on the right upper arm. In the experimental group (Tourniquet with exsanguination, T (e) ), the arm was additionally exsanguinated using an Esmarch bandage. Cutaneous microcirculation parameters (oxygen saturation [SO (2) ], blood flow [BF], and relative amount of hemoglobin [rHb]) were assessed non-invasively with the oxygen to see (O2C) device. RESULTS: Both groups showed significant changes in all microcirculatory parameters compared with baseline. Although SO (2) and BF values tended to be higher during reperfusion in the experimental group (T (e) ), overall differences were not statistically significant (except at the end of the first reperfusion phase in BF [T (mean) 1.33 ± 0.54 vs. T (e) (mean) 1.93 ± 0.91; p  = 0.017] and at the beginning of the second reperfusion phase in SO (2) [T (mean) 1.05 ± 0.18 vs. T (e) (mean) 1.13 ± 0.17; p  = 0.045], respectively). CONCLUSION: Exsanguination, in addition to tourniquet application, does not enhance cutaneous microcirculation in RIC protocols. The relatively small sample size remains a limitation and restricts generalizability. Future studies should confirm these findings in larger and more diverse cohorts and explore potential clinical applications.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。